Medtronic Issues Recall for Newly-Approved Heart Device

Leading medical device manufacturer Medtronic has issued its second recall in as many weeks involving recently developed technology. Coming off of the European recall of its MiniMed 640 insulin pump last week, which is scheduled for a Pre-Market Approval (PMA) review in the U.S. later this year, the company has recalled nearly 7,000 EnVeo R


DOJ Subpoenas Allergan as Generics Antitrust Probe Widens

In the wake of a buying and selling frenzy, Irish drugmaker Allergan has been subpoenaed by the Department of Justice (DOJ) over antitrust concerns regarding the pricing of its generic drugs. Last week, the company announced a $40.5 billion selloff of its generics unit to the global generic market leader, Israeli-based Teva Pharmaceuticals. That deal



In Memoriam: Labor Health Crusader Dr. Donald L. Rasmussen

The New York Times paid tribute yesterday to a man whose death nearly went unnoticed in a national sense, but whose life needs to be celebrated. Dr. Donald L. Rasmussen died on July 23rd in Beckley, West Virginia at the age of 87. According to his stepdaughter, Julia Holliday, Dr. Rasmussen died from complications following


Medicare Turns 50 as the NOTICE Act awaits President Obama’s Signature

7/31/2015 The U.S.’s fundamental national healthcare program Medicare, as well as Medicaid officially turned 50 years-old on Thursday. President Lyndon Johnson signed an amendment to the Social Security Act which set the programs into law on July 30th, 1965. Medicare, the landmark program for seniors, now enrolls 55.2 million Americans. While a recent Kaiser Family


Will Medtronic’s MiniMed 640 Pump Glitch affect its PMA Status?

7/29/2015 Minnesota-based device giant Medtronic has issued letters to nearly 2,000 owners of the MiniMed 640 and 620 insulin pumps in Europe, warning them of a potential glitch in the reading mechanism. According to the letter, there is an error with the Bolus Wizard screen, causing it to not time-out and instead giving an outdated



Teva Inks $40.5 Billion Deal to Acquire Allergan’s Generics Unit

7/28/2015 The global pharmaceutical landscape was significantly altered on Monday as Israeli drugmaker Teva announced that it will purchase the generic drug business of Dublin-based Allergan. The move will put a stranglehold on Teva’s top sales position in the generic drug market, acquiring its third-largest competitor. Teva will purchase the generics unit for $40.5 billion,


FDA Proposes Detailed Added Sugar Guides on Food Labels

7/27/2015 In a move opposed by many food and drink manufacturers, the Food and Drug Administration (FDA) issued a proposal on Friday to requiring the industry to include detailed added sugar consumption levels in their products. The proposal is an update to the FDA’s 2014 proposed mandate requiring companies to list the amount of added


Former Executive Could Face Life for Peanuts

7/24/2015 The U.S. Probation Office has recommended that the former owner of Peanut Corporation of America, Stewart Parnell, be sentenced to life in prison for allowing several shipments of peanuts from facilities infected with salmonella. The peanuts led to the deadliest food outbreak in U.S. history from 2008-2009, causing nine deaths and over 700 illnesses